40 results
8-K
EX-2.1
RVLPQ
RVL Pharmaceuticals plc
27 Nov 23
Bankruptcy or Receivership
4:06pm
Statement, the Ballots (all of the foregoing, the “Solicitation Package” and such transmittal of the Solicitation Package to the Voting Classes … the Plan was timely, adequate, and sufficient under the circumstances. The Solicitation Package and Solicitation of votes on the Plan was appropriate
8-K
EX-10.1
RVLPQ
RVL Pharmaceuticals plc
20 Oct 23
Entry into a Material Definitive Agreement
5:00pm
labels and labeling (including package inserts) and product information are in material compliance with applicable FDA and other Regulatory Agency
424B5
omgtmb
8 Oct 21
Prospectus supplement for primary offering
5:13pm
424B5
2q3w398uiq34uw vjwt1
6 Oct 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-10.1
7b6hiwzya4syfpgmibl
6 Oct 21
Entry into a Material Definitive Agreement
4:22pm
424B5
pu5f18nu jt
8 Sep 21
Prospectus supplement for primary offering
7:01am
8-K
EX-99.1
6nx20p ws
8 Sep 21
Other Events
6:22am
8-K
EX-2.1
t3kp236jikl
30 Jun 21
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
6:04am
424B5
u8bdm
15 Jul 20
Prospectus supplement for primary offering
4:52pm
424B5
p9k6quh
14 Jul 20
Prospectus supplement for primary offering
12:00am
424B4
smg5chv4 2xc3868sn
10 Jan 20
Prospectus supplement with pricing info
4:19pm